Top Funding Round of the Week: Biotech and Space Tech Bring in the Money

Do you want to check out the biggest financing deals starting in 2024 with our curated list of $100 million-plus deals in US-based companies? Check out the Crunchbase Megadeals Board.

A weekly rundown of the week’s top 10 top-grossing campaigns in the US Check out last week’s top-grossing campaigns here.

By now 2025 chaos has come as far as major cycles go. Last week more than ten companies raised $100 million or more. This week there are few, not many, because companies need to raise $100 million to make this list.

1. Truveta, $320M, biotechnology: Medical data analytics company Truveta has secured a $320 million round of funding from Regeneron Pharmaceuticals, Illumina and 17 US health systems as it continues to build the world’s largest integrated database. Privately held Truveta’s market value is over $1 billion. Truveta integrates clinical data from its partner organizations related to treatment and outcomes and other health aspects. Its status is updated daily. Founded in 2020, the company has raised $515 million, according to Crunchbase.

2. Stoke Space, $260M, available: Recycled rocket startup Stoke Space has locked in a $260 million Series C as the space technology group looks to build a 2024 success in terms of fundraising. A Kent, Washington-based company is developing reusable rockets that could get the lowest cost into space. It is expected to use the new funding to complete the construction of its Nova vehicle at the Cape Canaveral Space Force Station in Florida. The new round includes new and existing investors including Breakthrough Energy Ventures, Glade Brook Capital Partners, Seven Seven Six and the University of Michigan, among others. Founded in 2019, Stoke has raised more than $ 480 million, for the company. After a slow 2023, last year saw a recovery for the technology industry in terms of business financing. In 2024, VC-backed space tech startups raised $8.3 billion, according to Crunchbase data. That number is a 17% jump from the $7.1 billion raised in 2023, but less than the $9.2 billion funded in 2022.

3. Colossal Biosciences, $200M, genetics: Colossal Biosciences, a startup looking at ways to bring back the dodo bird and the woolly mammoth, raised $200 million Series C at a $10.2 billion valuation. The new cash came from TWG Global, a joint venture led by Mark Walter and Thomas Tull. The Dallas start-up, which launched in 2021, plans to use the money to continue expanding its engineering technology, as well as expanding its software and tools for applications including destruction, conservation and human health. According to the company, bringing back dead animals can provide a better understanding of evolutionary changes in other species, and the use of engineering will also help improve food production and reduce the impact of the environment. In January 2023 Colossal Biosciences raised a $150 million Series B to expand its reach. The round was led by Tull’s US Innovative Technology Fund. Since launching in September 2021, Colossal has raised $435 million, for the company.

4. Tune Therapeutics, $175M, biotechnology: Epigenetic programming startup Tune Therapeutics raised a $175 million round led by Hevolution, New Enterprise Associates, Regeneron Ventures and Yosemite. The funding is expected to advance the development of the company’s existing pipeline, which is currently anchored by its drug Epigenetic silencing therapy for chronic Hepatitis B. Founded in 2020, the company has raised $215 million, according to Crunchbase.

5. Loft Orbital, $170M, available: Loft space startup Orbital received $170 million in funding led by Axial Partners and Tikehau Capital. The San Francisco-based company builds satellites that allow customers to attach components such as sensors and telescopes. Founded in 2017, the company has raised $326 million, according to Crunchbase.

6. Caidya, $165M, biotechnology: Raleigh, North Carolina-based Caidya, a private research organization, locked in a growth investment of $165 million from funds managed by Rubicon Founders, an investment company for healthcare in the United States. Caidya offers biopharma companies a range of clinical trial services from regulatory and clinical delivery monitoring of consent. Based in 2021, this is the first round that has been raised with a visible amount, according to Crunchbase.

7. Phantom, $150M, crypto: San Francisco-based Phantom Technologies, a crypto wallet, raised a $150 million round led by Paradigm and Sequoia Capital, valuing the startup at $3 billion. Founded in 2021, the company has raised $268 million, according to Crunchbase.

8. (free) Harbinger, $100M, electric car: Los Angeles-based commercial electronics firm Harbinger has raised a $100 million Series B round led by Capricorn Investor Group and Leitmotif. Founded in 2021, the company has raised more than $200 million, according to Crunchbase.

8. (free) Instabase, $100M, data: San Francisco-based Instabase, which creates artificial intelligence-powered data to help companies manage unstructured data, locked in $100 million Series D led by Qatar Investment Authority. Founded in 2015, the company has raised $292 million, according to Crunchbase.

8. (free) Umoja Biopharma, $100M, biotechnology: Seattle-based Umoja Biopharma, an in vivo biopharmaceutical developer, announced the closing of a $100 million Series C round led by DCVC Bio and Double Point Ventures. Founded in 2019, the company has raised $363 million, according to Crunchbase.

World’s largest shopping mall

Most of the investment this week went to a Chinese-based company.

• Smart Fabric, which provides online solutions for the textile industry, raised a $460 million Series C round.

Methods

We checked the number of rounds of announcements in the Crunchbase database collected by American companies for the seven days of January 11 to January 17. Although many rounds of announcements are represented in the database, six in have some downtime. because some rounds are reported late in the week.

Example: Dom Guzman